NO951628L - Transformerte endotelceller - Google Patents
Transformerte endotelcellerInfo
- Publication number
- NO951628L NO951628L NO951628A NO951628A NO951628L NO 951628 L NO951628 L NO 951628L NO 951628 A NO951628 A NO 951628A NO 951628 A NO951628 A NO 951628A NO 951628 L NO951628 L NO 951628L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- kappa
- endothelial cells
- activity
- endothelial
- Prior art date
Links
- 210000002889 endothelial cell Anatomy 0.000 title abstract 4
- 102000008379 I-kappa B Proteins Human genes 0.000 abstract 3
- 108010021699 I-kappa B Proteins Proteins 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 238000002689 xenotransplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929222931A GB9222931D0 (en) | 1992-11-02 | 1992-11-02 | Organic compounds |
| PCT/EP1993/003015 WO1994010305A1 (en) | 1992-11-02 | 1993-10-29 | Transformed endothelial cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951628D0 NO951628D0 (no) | 1995-04-28 |
| NO951628L true NO951628L (no) | 1995-07-03 |
Family
ID=10724398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951628A NO951628L (no) | 1992-11-02 | 1995-04-28 | Transformerte endotelceller |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0669977B1 (de) |
| JP (1) | JPH08502653A (de) |
| KR (1) | KR950704477A (de) |
| AT (1) | ATE192492T1 (de) |
| AU (1) | AU680636B2 (de) |
| CA (1) | CA2143489A1 (de) |
| DK (1) | DK0669977T3 (de) |
| ES (1) | ES2146235T3 (de) |
| FI (1) | FI952088A0 (de) |
| GB (1) | GB9222931D0 (de) |
| GR (1) | GR3033600T3 (de) |
| NO (1) | NO951628L (de) |
| NZ (1) | NZ257539A (de) |
| PT (1) | PT669977E (de) |
| RU (1) | RU2164415C2 (de) |
| WO (1) | WO1994010305A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2726005B1 (fr) * | 1994-10-10 | 1997-01-03 | Adim | Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques |
| WO1996030532A1 (en) * | 1995-03-24 | 1996-10-03 | Novartis Ag | Gene therapy for transplantation and inflammatory or thrombotic conditions |
| AU5289596A (en) * | 1995-04-13 | 1996-10-30 | Chugai Seiyaku Kabushiki Kaisha | Peptide suppressing ixbalpha phosphorylation |
| JPH0959151A (ja) * | 1995-08-24 | 1997-03-04 | Kao Corp | ＮＦ−κＢ活性化抑制剤 |
| EP0779361A3 (de) | 1995-12-15 | 1999-11-10 | F. Hoffmann-La Roche Ag | Verkürzte Form von Kappa B Inhibitor-Protein, rekombinanter Herstellung und Verwendung |
| WO1997030083A1 (en) * | 1996-02-14 | 1997-08-21 | Novartis Ag | Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| AU2001231009A1 (en) | 2000-01-21 | 2001-07-31 | Beth Israel Deaconess Medical Center | Use of pro-apoptotic factors in treatment of atherosclerosis |
| AU2004320466A1 (en) * | 2003-06-11 | 2006-02-02 | Jan Remmereit | Nuclear reprogramming of cells for therapeutic use |
| TW201120210A (en) | 2009-11-05 | 2011-06-16 | Hoffmann La Roche | Glycosylated repeat-motif-molecule conjugates |
| BR112013024781B1 (pt) | 2011-04-01 | 2021-09-08 | Chugai Seiyaku Kabushiki Kaisha | Métodos de produção de um anticorpo e de uma composição farmacêutica |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68910682T2 (de) * | 1988-03-01 | 1994-06-01 | Whitehead Biomedical Inst | Aktivierung der nf-kappa b-vorstufe. |
| AU659824B2 (en) * | 1990-10-31 | 1995-06-01 | Cell Genesys, Inc. | Retroviral vectors useful for gene therapy |
-
1992
- 1992-11-02 GB GB929222931A patent/GB9222931D0/en active Pending
-
1993
- 1993-10-29 NZ NZ257539A patent/NZ257539A/en unknown
- 1993-10-29 DK DK93924544T patent/DK0669977T3/da active
- 1993-10-29 JP JP6510706A patent/JPH08502653A/ja active Pending
- 1993-10-29 ES ES93924544T patent/ES2146235T3/es not_active Expired - Lifetime
- 1993-10-29 EP EP93924544A patent/EP0669977B1/de not_active Expired - Lifetime
- 1993-10-29 AU AU54404/94A patent/AU680636B2/en not_active Ceased
- 1993-10-29 CA CA002143489A patent/CA2143489A1/en not_active Abandoned
- 1993-10-29 RU RU95110697/14A patent/RU2164415C2/ru active
- 1993-10-29 AT AT93924544T patent/ATE192492T1/de not_active IP Right Cessation
- 1993-10-29 PT PT93924544T patent/PT669977E/pt unknown
- 1993-10-29 KR KR1019950701716A patent/KR950704477A/ko not_active Application Discontinuation
- 1993-10-29 WO PCT/EP1993/003015 patent/WO1994010305A1/en active IP Right Grant
-
1995
- 1995-04-28 NO NO951628A patent/NO951628L/no not_active Application Discontinuation
- 1995-05-02 FI FI952088A patent/FI952088A0/fi unknown
-
2000
- 2000-06-30 GR GR20000401135T patent/GR3033600T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2143489A1 (en) | 1994-05-11 |
| GR3033600T3 (en) | 2000-09-29 |
| NZ257539A (en) | 1996-08-27 |
| NO951628D0 (no) | 1995-04-28 |
| WO1994010305A1 (en) | 1994-05-11 |
| ATE192492T1 (de) | 2000-05-15 |
| ES2146235T3 (es) | 2000-08-01 |
| AU5440494A (en) | 1994-05-24 |
| FI952088A (fi) | 1995-05-02 |
| KR950704477A (ko) | 1995-11-20 |
| AU680636B2 (en) | 1997-08-07 |
| EP0669977B1 (de) | 2000-05-03 |
| GB9222931D0 (en) | 1992-12-16 |
| DK0669977T3 (da) | 2000-08-07 |
| PT669977E (pt) | 2000-08-31 |
| RU2164415C2 (ru) | 2001-03-27 |
| EP0669977A1 (de) | 1995-09-06 |
| FI952088A0 (fi) | 1995-05-02 |
| JPH08502653A (ja) | 1996-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3280479D1 (de) | Rekombinante DNS-Mittel und Verfahren | |
| DE69420726D1 (de) | Embryonische stammzelle zur herstellung von chimäre und transgen-ongulaten | |
| DE69333466D1 (de) | Herstellung von transplantatgeweben aus extrazellulärer matrix | |
| ES2093025T3 (es) | Produccion del factor de crecimiento de celulas endoteliales y adn de codificacion del mismo. | |
| DE69534227D1 (de) | Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten | |
| EE9700018A (et) | Bioloogilistesse tehiselunditesse kapseldatud rakkude kasvu kontrollimine | |
| DK0669977T3 (da) | Transformerede endothelceller | |
| ATE211177T1 (de) | Expression von aktivem menschlichem protein c im milchdrüsengewebe transgener tiere | |
| ATE71298T1 (de) | Immunoregulation. | |
| CA2095861A1 (en) | Structural proteins from artificial genes | |
| ATE360701T1 (de) | Putrescin-n-methyltransferasepromotor | |
| DK0744891T3 (da) | Transgene fibrinogener | |
| ES2005498A6 (es) | Un producto fibroso no tejido. | |
| ZA843015B (en) | Novel strain of trichoderma harzianum,method of isolating said strain,method of cultivating said strain,novel peptides or compounds produced from said strain,and application of said strain and of said novel peptides or of the product obtained by the cultivation method as a biologically active means in the form of a plant-disease control product | |
| PT1621633E (pt) | Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase | |
| ATE286129T1 (de) | Pflanzenwurzelspezifischer promotor, rekombinante vektoren und wirtszellen die diesen enthalten und korrespondierende transgene pflanzen | |
| IL91355A0 (en) | Plant elongation factor,promoters,coding sequences and uses | |
| DE69331434D1 (de) | Mutanter AOX2 Promotor, diesen enthaltender Vektor, transformierte Zellen und Herstellung von heterologen Proteinen | |
| DE59914540D1 (de) | Transgene pflanzen und pflanzenzellen mit verminderter expression von invertaseinhibitoren | |
| ATE90969T1 (de) | Expression von fremden genen in drosophilazellen. | |
| ATE401001T1 (de) | Pflanzen zur kontrolle von schäden verursacht durch fressende insekten | |
| ES2027104A6 (es) | Composicion herbicida dotada de antidoto, composicion antidoto, metodo de control selectivo de malas hierbas y metodo de tratar semillas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |